Green Cross Health Limited (NZE:GXH)
New Zealand · Delayed Price · Currency is NZD 1.970
+0.020 (1.03%)
Sep 11, 2026, 1:34 PM NZST
Green Cross Health Ratios and Metrics
Market cap in millions NZD. Fiscal year is April - March.
Millions NZD. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 280 | 172 | 108 | 146 | 193 | 190 | |
Market Cap Growth | 124.32% | 60.13% | -26.40% | -24.35% | 1.60% | 29.13% |
Enterprise Value | 392 | 298 | 235 | 272 | 283 | 276 |
Last Close Price | 1.95 | 1.16 | 0.68 | 0.87 | 0.87 | 0.80 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 13.77 | 8.46 | 6.74 | 12.45 | 4.28 | 7.97 |
Forward PE | - | 7.73 | 7.73 | 7.73 | 7.73 | 7.73 |
PS Ratio | 0.51 | 0.32 | 0.21 | 0.29 | 0.39 | 0.40 |
PB Ratio | 1.47 | 0.90 | 0.60 | 0.86 | 0.96 | 1.11 |
P/TBV Ratio | 28.22 | 17.35 | 168.81 | - | 5.32 | - |
P/FCF Ratio | 6.23 | 3.83 | 2.30 | 3.80 | 4.81 | 3.08 |
P/OCF Ratio | 5.14 | 3.16 | 2.05 | 3.18 | 4.21 | 2.89 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 0.72 | 0.55 | 0.45 | 0.54 | 0.57 | 0.58 |
EV/EBITDA Ratio | 5.95 | 6.17 | 5.61 | 7.25 | 7.17 | 5.15 |
EV/EBIT Ratio | 8.65 | 6.91 | 6.33 | 8.70 | 8.54 | 5.81 |
EV/FCF Ratio | 8.70 | 6.62 | 5.02 | 7.07 | 7.04 | 4.47 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.65 | 0.65 | 0.75 | 0.85 | 0.61 | 0.69 |
Debt / EBITDA Ratio | 1.96 | 1.96 | 2.39 | 2.79 | 2.25 | 1.65 |
Debt / FCF Ratio | 2.77 | 2.77 | 2.89 | 3.75 | 3.06 | 1.90 |
Net Debt / Equity Ratio | 0.51 | 0.51 | 0.60 | 0.71 | 0.32 | 0.42 |
Net Debt / EBITDA Ratio | 2.00 | 2.00 | 2.60 | 3.23 | 1.64 | 1.35 |
Net Debt / FCF Ratio | 2.14 | 2.14 | 2.33 | 3.14 | 1.61 | 1.17 |
Asset Turnover | 1.40 | 1.40 | 1.36 | 1.29 | 1.22 | 1.23 |
Inventory Turnover | 14.15 | 14.15 | 14.59 | 14.35 | 13.58 | 13.02 |
Quick Ratio | 0.60 | 0.60 | 0.58 | 0.58 | 0.93 | 0.67 |
Current Ratio | 0.98 | 0.98 | 0.97 | 0.95 | 1.28 | 0.91 |
Return on Equity (ROE) | 13.93% | 13.93% | 11.82% | 8.51% | 10.88% | 18.34% |
Return on Assets (ROA) | 6.93% | 6.93% | 6.04% | 4.99% | 5.11% | 7.66% |
Return on Invested Capital (ROIC) | 10.85% | 10.80% | 9.19% | 7.93% | 9.73% | 14.16% |
Return on Capital Employed (ROCE) | 14.40% | 14.40% | 12.30% | 10.50% | 10.70% | 17.40% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 7.27% | 11.83% | 14.83% | 8.04% | 23.39% | 12.55% |
FCF Yield | 16.05% | 26.10% | 43.46% | 26.35% | 20.78% | 32.43% |
Dividend Yield | 5.68% | 7.31% | 7.76% | 5.20% | 8.05% | 8.08% |
Payout Ratio | 40.67% | 40.67% | 40.59% | 415.88% | 22.27% | 18.05% |
Buyback Yield / Dilution | -0.12% | -0.12% | -0.10% | 0.04% | -0.11% | -0.24% |
Total Shareholder Return | 5.56% | 7.19% | 7.66% | 5.24% | 7.94% | 7.84% |